• FirefoxInstall the new Firefox »
  •  Dow Down1.11% Nasdaq Down0.94%

    Idera Pharmaceuticals, Inc. (IDRA)

    -NasdaqCM
    3.71 Up 0.14(3.92%) 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 2   30   38   3  
    Cost of Revenue -   -   -   -  
    Gross Profit 2   30   38   3  
    Operating Expenses
    Research Development8,245  6,678  5,637  6,933  
    Selling General and Administrative3,686  2,873  2,730  2,043  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (11,929) (9,521) (8,329) (8,973)
    Income from Continuing Operations
    Total Other Income/Expenses Net11  66  21  12  
    Earnings Before Interest And Taxes(11,918)(9,455)(8,308)(8,961)
    Interest Expense -   -   -   -  
    Income Before Tax(11,918)(9,455)(8,308)(8,961)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(11,918)(9,455)(8,308)(8,961)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (11,918) (9,455) (8,308) (8,961)
    Preferred Stock And Other Adjustments(97)(119)(118)(185)
    Net Income Applicable To Common Shares (12,015) (9,574) (8,426) (9,146)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.